ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Neuralstem Inc

Neuralstem Inc (CUR)

1.52
0.00
(0.00%)
마감 26 12월 6:00AM
0.00
0.00
(0.00%)
시간외 거래: -
고급 차트
Rendering Error

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
1.52
매수가
1.58
매도가
1.62
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
market_cap
전일 종가
1.52
개장가
-
최근 거래 시간
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
-
발행 주식
9,217,000
배당수익률
-
주가수익률
-1.14
주당순이익(EPS)
-1.33
매출
250k
순이익
-12.3M

Neuralstem Inc 정보

Neuralstem Inc is a clinical-stage biopharmaceutical company. The company is engaged in research, development, and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. Its technology base has produced three p... Neuralstem Inc is a clinical-stage biopharmaceutical company. The company is engaged in research, development, and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. Its technology base has produced three primary assets: NSI-189 small molecule program, NSI-566 stem cell therapy program and novel and proprietary new chemical entity screening platform. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
웹사이트
본부
Camden, Delaware, USA
설립됨
-

CUR 최신 뉴스

NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COV...

RADNOR, Pa., March 19, 2021 (GLOBE NEWSWIRE) -- NeuroRx, Inc. announced the first patient in its P2/3 study of inhaled ZYESAMI™ in the treatment of moderate and severe COVID-19 (AVICOVID-2) was...

Letter from Seneca Biopharma's Executive Chairman

Letter from Seneca Biopharma's Executive Chairman PR Newswire GERMANTOWN, Md., Sept. 2, 2020 GERMANTOWN, Md., Sept. 2, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a...

Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering

Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering PR Newswire GERMANTOWN, Md., May 27, 2020 GERMANTOWN, Md., May 27, 2020 /PRNewswire/ -- Seneca Biopharma, Inc...

Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA

Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA PR Newswire GERMANTOWN, Md., Oct. 31, 2019 GERMANTOWN, Md., Oct. 31, 2019 /PRNewswire/ -- Seneca Biopharma, Inc., (Nasdaq: CUR), a...

Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto...

Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases PR Newswire GERMANTOWN, Md., Oct. 30, 2019...

Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit

Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit PR Newswire GERMANTOWN, Md., Oct. 28, 2019 GERMANTOWN, Md., Oct. 28, 2019 /PRNewswire/...

Neuralstem Becomes Seneca Biopharma

Neuralstem Becomes Seneca Biopharma PR Newswire GERMANTOWN, Md., Oct. 28, 2019 GERMANTOWN, Md., Oct. 28, 2019 /PRNewswire/ -- Neuralstem, Inc. (NASDAQ:CUR), announces that the company has changed...

Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)

Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4) PR Newswire GERMANTOWN, Md., Oct. 3, 2019 GERMANTOWN, Md., Oct. 3, 2019 /PRNewswire/ -- Neuralstem, Inc...

Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Pat...

Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Patients PR Newswire GERMANTOWN, Md., Sept. 24, 2019 GERMANTOWN, Md...

Neuralstem Reports Second Quarter 2019 Fiscal Results

Neuralstem Reports Second Quarter 2019 Fiscal Results PR Newswire GERMANTOWN, Md., Aug. 14, 2019 GERMANTOWN, Md., Aug. 14, 2019 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CUR - Frequently Asked Questions (FAQ)

What is the current Neuralstem share price?
The current share price of Neuralstem is US$ 1.52
How many Neuralstem shares are in issue?
Neuralstem has 9,217,000 shares in issue
What is the market cap of Neuralstem?
The market capitalisation of Neuralstem is USD 14.01M
What is the 1 year trading range for Neuralstem share price?
Neuralstem has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Neuralstem?
The price to earnings ratio of Neuralstem is -1.14
What is the cash to sales ratio of Neuralstem?
The cash to sales ratio of Neuralstem is 56.09
What is the reporting currency for Neuralstem?
Neuralstem reports financial results in USD
What is the latest annual turnover for Neuralstem?
The latest annual turnover of Neuralstem is USD 250k
What is the latest annual profit for Neuralstem?
The latest annual profit of Neuralstem is USD -12.3M
What is the registered address of Neuralstem?
The registered address for Neuralstem is 2140 S DUPONT HWY, CAMDEN, DELAWARE, 19934
What is the Neuralstem website address?
The website address for Neuralstem is www.palisadebio.com.
Which industry sector does Neuralstem operate in?
Neuralstem operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BAOSBaosheng Media Group Holdings Ltd
US$ 7.10
(310.40%)
58.74M
HOURHour Loop Inc
US$ 4.40
(207.69%)
97.42M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
CREVCarbon Revolution Public Ltd
US$ 9.16
(135.48%)
26.95M
AVGRAvinger Inc
US$ 1.45
(125.72%)
107.53M
SLGLSol Gel Technologies Ltd
US$ 0.9798
(-40.62%)
3.07M
DRCTDirect Digital Holdings Inc
US$ 3.71
(-32.55%)
23.82M
CHEKCheck Cap Ltd
US$ 1.55
(-31.11%)
3.49M
SYTASiyata Mobile Inc
US$ 0.5178
(-30.83%)
2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15.47
(-30.38%)
147.98k
SVMHSRIVARU Holding Ltd
US$ 0.0338
(20.71%)
280.27M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
LITMSnow Lake Resources Ltd
US$ 0.5849
(52.84%)
181.22M
LCIDLucid Group Inc
US$ 3.20
(3.23%)
108.75M
RGTIRigetti Computing Inc
US$ 11.35
(3.56%)
108.38M

CUR 금융

금융
Rendering Error
rx7171 rx7171 4 분 전
I hope no distribution deal until the MAA approved.
Will get the best deal and no need to rush.
AVXL
iclight iclight 5 분 전
They will never get approval. I’ve been saying that longer than you’ve been failing to understand how trials work.

Please repost all of your wrong price and approval date predictions from your delusional high horse.
NWBO
rx7171 rx7171 5 분 전
I hope no distribution deal until the MAA approved.
Will get the best deal and no need to rush.
AVXL
Ppastis Ppastis 7 분 전
Xmas day .., and still keep telling bS ???


Can you all imagine there is a war ( 3rd ww  ? Have you ?
If even people with a different mindeset cannot agree ???
People cannot find a way to communicate about a stock  ?? Really ??
Sad sad people !!
LWLG
Backstabbed Backstabbed 7 분 전
$MIKP - let's go Bauer. Don't you need some liquidity in your stock?
MIKP
chemist72 chemist72 7 분 전
MVNT got left behind from the original plans You nailed it.

It seems HiAlloy Valve is the only entity that Linh plans for MVNT. If that's the case, then MVNT will never amount to anything substantial. And I'm sure Linh knows this. Why would he want to merge his JV partners with MVNT?
MVNT
Louie_Louie Louie_Louie 8 분 전
Same to you, lmao. FFFFannieheyyyyy ha ha ha
Orange Cassidy Orange Cassidy 9 분 전
Hit dogs holler! Merry Christmas
NBRI
bigtalan bigtalan 9 분 전
Merry Christmas to all .
RSPI
Horseb4CarT Horseb4CarT 9 분 전
Amen!

Adding to Gary's always cogent and even keeled comments about the market system, it's reminiscent of the old line, paraphrasing, "they rob banks because that's where the money is."

The markets are where a whole lot of money is, and as the Mathew McKonahey (sp?) ch
NWBO
Monroe1 Monroe1 11 분 전
Speak a bit louder sad sack. You get overtime for holidays?
NBRI
NeoSunTzu NeoSunTzu 12 분 전
And let us not forget Neo's GSE Corollary ...
Governments can remain corrupt longer than you can remain invested and liquid
FNMA
hedge_fun hedge_fun 12 분 전
10 months and 10 days ago, Tony lied…..

about APRU owning Lena, and you’re just now wondering if he’s throwing longs under the bus?

Speaking of buses, how long was the one you rode to school on?

It’s rhetorical.

Merry Christmas!
APRU
Jimmy Joe Jimmy Joe 12 분 전
You too cardmaster. Our day will come or not.

Either way, I am not selling or leaving.
DBMM
jimr1717 jimr1717 12 분 전
Only 3 trading days left for those to take their tax loss.
Once again SINT has came through with this benefit.
Gifting employees with shares was another brilliant idea to keep this going.
I would look forward to seeing 2025’s offering to be greater than previous years.
SINT
Here Today Here Today 12 분 전
No it was not SOUN that McDonalds did not like. 

McDonalds is supposedly looking at SOUN now if you read the Entrepreneur article that was posted.
SOUN
BOREALIS BOREALIS 12 분 전
YES. Merry Christmas everyone

https://static.toiimg.com/thumb/msid-116467250,width-400,resizemode-4/116467250.jpg
getmoreshares getmoreshares 14 분 전
did everyone get their COAL???????????
getmoreshares getmoreshares 15 분 전
did everyone get their COAL???????????
CGAC
learningcurve2020 learningcurve2020 15 분 전
GuruGary's sure doing the hard sell on Christmas Day.  Can't tell if it's nerves or just shilling?? 
NWBO
janice shell janice shell 18 분 전
That sounds very interesting.
cjstocksup cjstocksup 20 분 전
Reagan, very wise words.
https://x.com/elonmusk/status/1871520121212346496

최근 히스토리

Delayed Upgrade Clock